NanoVibronix Inc (NanoVibronix) is a medical device company that offers therapeutic ultrasound technology solutions to heal and relieve pain anf nerve problems. Its products include pain relief drugs and medical devices, ultra sound devices, urology therapy devices among others. Urology therapy devices include disposable clip and driver. The company markets its products under the brands such as PainShield and UroShield. The company’s products offer solutions for relieving chronic and acute pain and treatment for trigeminal neuralgia. It operates in the US and Israel. NanoVibronix is headquartered in Elmsford, New York, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company NanoVibronix Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- NanoVibronix Inc Company Overview
- NanoVibronix Inc Company Snapshot
- NanoVibronix Inc Pipeline Products and Ongoing Clinical Trials Overview
- NanoVibronix Inc - Pipeline Analysis Overview
- NanoVibronix Inc - Key Facts
- NanoVibronix Inc - Major Products and Services
- NanoVibronix Inc Pipeline Products by Development Stage
- NanoVibronix Inc Ongoing Clinical Trials by Trial Status
- NanoVibronix Inc Pipeline Products Overview
- LungShield
- LungShield Product Overview
- PainShield CBD Infused Patch
- PainShield CBD Infused Patch Product Overview
- PainShield Relief - OTC
- PainShield Relief - OTC Product Overview
- PainShield Relief - OTC Clinical Trial
- Renooskin
- Renooskin Product Overview
- TrachShield
- TrachShield Product Overview
- Uroshield
- Uroshield Product Overview
- Uroshield Clinical Trial
- NanoVibronix Inc - Key Competitors
- NanoVibronix Inc - Key Employees
- NanoVibronix Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- NanoVibronix Inc, Recent Developments
- Aug 11, 2022: NanoVibronix announce quarter ended June 30, 2022
- Jan 19, 2022: NanoVibronix files three U.S. patent applications further leveraging its innovative surface acoustic wave technology
- Jan 13, 2022: NanoVibronix Expands Board of Directors with Appointment of Two New Independent Directors
- Aug 17, 2021: NanoVibronix Announces Results of Annual Meeting of Stockholders Held
- Dec 02, 2019: NanoVibronix to present at two investor conferences in December
- Nov 18, 2019: NanoVibronix PainShield device receives unique reimbursement code from Centers for Medicare and Medicaid (CMS)
- Sep 03, 2019: NanoVibronix and Marathon Medical to provide PainShield to VA Hospitals and the Department of Justice
- Aug 27, 2019: NanoVibronix reports significant progress with a leading global consumer healthcare company
- Aug 13, 2019: NanoVibronix signs distribution agreement with ProTrade Systems for PainShield(R) MD
- Jul 23, 2019: NanoVibronix nanounces License Agreement with Ideal Medical International for International Distribution of PainShield(R) and UroShield(R)
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- NanoVibronix Inc Pipeline Products and Ongoing Clinical Trials Overview
- NanoVibronix Inc Pipeline Products by Equipment Type
- NanoVibronix Inc Pipeline Products by Indication
- NanoVibronix Inc Ongoing Clinical Trials by Trial Status
- NanoVibronix Inc, Key Facts
- NanoVibronix Inc, Major Products and Services
- NanoVibronix Inc Number of Pipeline Products by Development Stage
- NanoVibronix Inc Pipeline Products Summary by Development Stage
- NanoVibronix Inc Ongoing Clinical Trials by Trial Status
- NanoVibronix Inc Ongoing Clinical Trials Summary
- LungShield - Product Status
- LungShield - Product Description
- PainShield CBD Infused Patch - Product Status
- PainShield CBD Infused Patch - Product Description
- PainShield Relief - OTC - Product Status
- PainShield Relief - OTC - Product Description
- PainShield Relief - OTC - The Effects of the NanoVibronix's PainShield Surface Acoustic Waves on the Symptoms of Lateral Epicondylitis
- Renooskin - Product Status
- Renooskin - Product Description
- TrachShield - Product Status
- TrachShield - Product Description
- Uroshield - Product Status
- Uroshield - Product Description
- Uroshield - Low Energy Surface Waves to Prevent Urinary Infections and Catheter Associated Symptoms Among Patients with Neurogenic Bladder Dysfunction
- Uroshield - The Effect of Surface Acoustic Waves on the Prevention of Bacterial Colonization in Longterm Indwelling Urinary Catheters
- NanoVibronix Inc, Key Employees
- NanoVibronix Inc, Other Locations
- NanoVibronix Inc, Subsidiaries
- Glossary
- NanoVibronix Inc Pipeline Products by Equipment Type
- NanoVibronix Inc Pipeline Products by Development Stage
- NanoVibronix Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Becton Dickinson and Co
- Abbott Laboratories
- Monarch Medical Diagnostics
- Avinger Inc
- GE Healthcare Medical Diagnostics
- Airxpanders, Inc.
- Kona Medical Inc
